Senate budget
This article was originally published in The Gray Sheet
Executive Summary
Appropriations Committee approves $1.1 bil. increase to NIH budget at Sept. 15 mark-up, bringing agency to $28.91 bil. for FY 2005. The Senate version represents an increase over a Sept. 9 House budget earmarking $28.51 bil. for NIH. The Senate bill echoes House recommendations that CMS develop a wheelchair coverage policy "firmly based on a functional standard" of what it means for a patient to be "non-ambulatory," including "beneficiaries who cannot perform their basic acts of daily living, toileting, food preparation and emergency egress." The Senate and House both note the cost-effectiveness of avoiding institutional care or hospitalization. At a Sept. 1 town meeting, CMS had proposed new payment codes to help combat power wheelchair fraud (1"The Gray Sheet" Sept. 6, 2004, p. 15)...
You may also be interested in...
Medicare Revisits Power-Wheelchair Codes; ECRI Wants More iBOT Studies
ECRI recommends larger, longer-term studies of Johnson & Johnson/Independence Technology's iBOT 3000 stair-climbing power wheelchair to better determine the device's cost-to-benefit ratio
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.